BEN Welcomes Former Permanente CEO and Healthcare Leader, Richard S. Isaacs, to Board of Directors
Brand Engagement Network Inc. (BNAI) has appointed Richard S. Isaacs, MD, FACS to its Board of Directors, effective August 26, 2024. Dr. Isaacs, currently Dean of the College of Medicine at California Northstate University, brings extensive experience in healthcare technology innovation and leadership. As former CEO of The Permanente Medical Group and Co-CEO of The Permanente Federation, he oversaw a network of 23,000 physicians and 80,000 staff. Dr. Isaacs led the development of Kaiser Permanente's electronic health record system and smartphone applications to enhance patient care. BEN CEO Paul Chang believes Dr. Isaacs' expertise will be important in transforming patient care through GenAI. Named one of the 100 Most Influential People in Healthcare by Modern Healthcare, Dr. Isaacs aims to guide BEN's development of safe, intelligent AI assistants in healthcare.
Brand Engagement Network Inc. (BNAI) ha nominato Richard S. Isaacs, MD, FACS nel suo Consiglio di Amministrazione, a partire dal 26 agosto 2024. Il Dott. Isaacs, attualmente Decano della Facoltà di Medicina presso la California Northstate University, porta con sé una vasta esperienza in innovazione tecnologica sanitaria e leadership. In qualità di ex CEO del The Permanente Medical Group e Co-CEO della The Permanente Federation, ha supervisionato una rete di 23.000 medici e 80.000 impiegati. Il Dott. Isaacs ha guidato lo sviluppo del sistema di cartelle cliniche elettroniche di Kaiser Permanente e delle applicazioni per smartphone per migliorare l'assistenza ai pazienti. Il CEO di BEN, Paul Chang, ritiene che l'esperienza del Dott. Isaacs sarà fondamentale per trasformare l'assistenza ai pazienti attraverso GenAI. Nominato tra le 100 persone più influenti nel settore sanitario da Modern Healthcare, il Dott. Isaacs punta a guidare lo sviluppo di assistenti AI intelligenti e sicuri nel settore sanitario da parte di BEN.
Brand Engagement Network Inc. (BNAI) ha nombrado a Richard S. Isaacs, MD, FACS en su Junta Directiva, a partir del 26 de agosto de 2024. El Dr. Isaacs, actualmente Decano de la Facultad de Medicina de la Universidad California Northstate, aporta una amplia experiencia en innovación tecnológica en salud y liderazgo. Como ex CEO de The Permanente Medical Group y Co-CEO de The Permanente Federation, supervisó una red de 23,000 médicos y 80,000 empleados. El Dr. Isaacs lideró el desarrollo del sistema de registros médicos electrónicos de Kaiser Permanente y aplicaciones para teléfonos inteligentes para mejorar la atención al paciente. Paul Chang, CEO de BEN, cree que la experiencia del Dr. Isaacs será importante para transformar la atención al paciente a través de GenAI. Nombrado una de las 100 personas más influyentes en el sector de la salud por Modern Healthcare, el Dr. Isaacs tiene como objetivo guiar el desarrollo de asistentes de IA seguros e inteligentes en la atención médica por parte de BEN.
Brand Engagement Network Inc. (BNAI)는 Richard S. Isaacs, MD, FACS를 2024년 8월 26일부로 이사회에 임명했습니다. 현재 캘리포니아 노스테이트 대학교 의과대학 학장인 이사크스 박사는 헬스케어 기술 혁신 및 리더십에 대한 폭넓은 경험을 가지고 있습니다. 그는 이전에 The Permanente Medical Group의 CEO이자 The Permanente Federation의 공동 CEO로 재직하며 23,000명의 의사와 80,000명의 직원을 감독했습니다. 이사크스 박사는 Kaiser Permanente의 전자 건강 기록 시스템과 환자 치료를 향상시키기 위한 스마트폰 애플리케이션 개발을 주도했습니다. BEN의 CEO인 폴 창은 이사크스 박사의 전문 지식이 GenAI를 통해 환자 치료 혁신에 중요한 역할을 할 것이라고 믿습니다. Modern Healthcare에 의해 헬스케어 분야에서 가장 영향력 있는 100인 중 한 명으로 선정된 이사크스 박사는 BEN의 안전하고 지능적인 AI 도우미 개발을 이끌어가고자 합니다.
Brand Engagement Network Inc. (BNAI) a nommé Richard S. Isaacs, MD, FACS au sein de son Conseil d'Administration, à compter du 26 août 2024. Le Dr Isaacs, actuellement Doyen de la Faculté de Médecine de l'Université de Californie Northstate, apporte une vaste expérience en innovation technologique dans le domaine de la santé et en leadership. Ancien CEO de The Permanente Medical Group et Co-CEO de The Permanente Federation, il a supervisé un réseau de 23 000 médecins et 80 000 employés. Le Dr Isaacs a dirigé le développement du système de dossiers médicaux électroniques de Kaiser Permanente et d'applications pour smartphones pour améliorer les soins aux patients. Paul Chang, CEO de BEN, pense que l'expertise du Dr Isaacs sera essentielle pour transformer les soins aux patients grâce à GenAI. Nommé parmi les 100 personnes les plus influentes dans le secteur de la santé par Modern Healthcare, le Dr Isaacs vise à guider le développement d'assistants IA sûrs et intelligents dans le secteur de la santé par BEN.
Brand Engagement Network Inc. (BNAI) hat Richard S. Isaacs, MD, FACS mit Wirkung zum 26. August 2024 in seinen Vorstand berufen. Dr. Isaacs, der derzeit Dekan der Fakultät für Medizin an der California Northstate University ist, bringt umfangreiche Erfahrung in Innovationstechnologie im Gesundheitswesen und Führung mit. Als ehemaliger CEO der The Permanente Medical Group und Co-CEO der The Permanente Federation überwachte er ein Netzwerk von 23.000 Ärzten und 80.000 Mitarbeitern. Dr. Isaacs leitete die Entwicklung des elektronischen Gesundheitsaktensystems von Kaiser Permanente und von Smartphone-Anwendungen zur Verbesserung der Patientenversorgung. Paul Chang, CEO von BEN, ist der Ansicht, dass Dr. Isaacs' Fachkenntnisse entscheidend für die Transformation der Patientenversorgung durch GenAI sein werden. Dr. Isaacs, der von Modern Healthcare zu den 100 einflussreichsten Personen im Gesundheitswesen ernannt wurde, hat das Ziel, die Entwicklung sicherer, intelligenter KI-Assistenten im Gesundheitswesen bei BEN zu leiten.
- Appointment of a highly experienced healthcare leader to the Board of Directors
- Potential for improved healthcare industry strategy and innovation
- Access to extensive network and expertise in healthcare technology
- None.
Dr. Isaacs' extensive background in healthcare technology innovation, along with his previous leadership experience in nationwide hospital and outpatient care, will help direct BEN's healthcare industry strategy
JACKSON, Wyo., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Brand Engagement Network Inc. (“BEN”), (Nasdaq: BNAI), an emerging provider of safe and secure customer engagement AI, today announced the appointment of Richard S. Isaacs, MD, FACS, to its Board of Directors, effective August 26, 2024. Dr. Isaacs is a renowned surgeon and is currently also serving as Dean of the College of Medicine and Professor of Otolaryngology at California Northstate University. His extensive expertise in clinical operations and strategic healthcare leadership will be a significant asset to BEN as the company continues to push the boundaries of innovation in healthcare.
Dr. Isaacs brings a wealth of experience to BEN through his renowned clinical expertise in otolaryngology and head and neck oncologic surgery, as well as his distinguished leadership background. As the former CEO and executive director of The Permanente Medical Group (TPMG), former president and CEO of the Mid-Atlantic Permanente Medical Group (MAPMG), and former Co-CEO of The Permanente Federation, Dr. Isaacs has overseen an enormous network, comprising 23,000 physicians and 80,000 nurses and staff, seeking to deliver high-quality health care to 12.6 million Kaiser Permanente members.
“In addition to technological advancements, true innovation in healthcare requires a deep understanding of the industry's complexities and the real-world challenges faced by both patients and providers,” said Paul Chang, CEO of BEN. “Dr. Isaacs' experience and leadership in healthcare technology innovation will be instrumental in our effort to transform patient care and empower medical professionals through our powerful GenAI.”
Named by Modern Healthcare as one of the 100 Most Influential People in Healthcare, Dr. Isaacs is celebrated for his transformative leadership and innovative contributions to the healthcare industry. Dr. Isaacs possesses an intimate understanding of the intersection of technology innovation and healthcare. He led the development and implementation of Kaiser Permanente’s electronic health record system during his tenure as physician in chief at Kaiser Permanente South Sacramento Medical Center, which led to the use of new smartphone applications to enhance patient experiences, personalize care, and drive high-quality care. His deep understanding of the challenges and opportunities within the healthcare system will be instrumental as BEN continues to develop solutions that address critical needs in the resource-constrained sectors and ever-evolving reality of healthcare.
“AI technology offers an incredible opportunity to vastly improve both healthcare professional operations and patient outcomes,” said Dr. Isaacs. “I have always pursued the realization of what is possible in healthcare with new technologies, and look forward to helping guide BEN’s development of new applications for the company’s safe, intelligent AI assistants in the industry.”
For more information about BEN please visit: http://www.beninc.ai.
About BEN
Brand Engagement Network (BEN), NASDAQ: BNAI, is an emerging provider of safe and secure generative AI for businesses and consumers, headquartered in Jackson, WY. BEN’s full-stack platform, encompassing front-end, middleware, and back-end, is scalable, customizable, and can be fully optimized for superior CX, productivity, and performance. The backbone of BENs success is its rich portfolio of conversational AI applications, featuring 16+ perception, understanding and response modules that facilitate human-like engagements with consumers. BEN seeks to deploy scalable and sustainable AI solutions to businesses and partner with those with complimentary capabilities and networks in industries experiencing significant workforce gaps. In line with the vision of an AI-enhanced world, BEN strives to bring AI assistants to everyone who can benefit from them.
Additional information about BEN can be found here: https://beninc.ai/
Forward-Looking Statements
This communication contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are not historical facts, and involve risks and uncertainties that could cause actual results of BEN to differ materially from those expected and projected. These forward-looking statements can be identified by the use of forward-looking terminology, including the words “anticipates,” “believes,” “continue,” “estimates,” “expects,” “intends,” “may,” “plans,” “potential,” “predicts,” “projects,” “should,” “will,” or “would,” or, in each case, their negative or other variations or comparable terminology.
These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Most of these factors are outside BEN’s control and are difficult to predict. Factors that may cause such differences include, but are not limited to, the risk factors that are described under the section titled “Risk Factors” in BEN’s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q subsequently filed with the Securities and Exchange Commission.
BEN cautions that the foregoing list of factors is not exclusive. BEN cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. BEN does not undertake nor does it accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based, and it does not intend to do so unless required by applicable law. Further information about factors that could materially affect BEN, including its results of operations and financial condition, is set forth under “Risk Factors” in BEN’s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q subsequently filed with the Securities and Exchange Commission.
No Offer or Solicitation
This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities of BEN or DHC or a solicitation of any vote or approval. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.
BEN Contacts
Investors:
Ryan Flanagan, ICR
ryan.flanagan@icrinc.com
Media:
Dan Brennan, ICR
dan.brennan@icrinc.com
FAQ
Who is the new Board member appointed by Brand Engagement Network (BNAI)?
What experience does Dr. Isaacs bring to Brand Engagement Network (BNAI)?
How might Dr. Isaacs' appointment impact Brand Engagement Network's (BNAI) healthcare strategy?
When did Dr. Isaacs join the Board of Directors of Brand Engagement Network (BNAI)?
